输血诊断市场规模、份额和成长分析（按产品类型、检测类型、最终用户、技术和地区划分）—2025-2032年产业预测

全球输血诊断市场预计在 2023 年达到 49 亿美元，从 2024 年的 51.8 亿美元成长到 2032 年的 80.7 亿美元，在预测期（2025-2032 年）内复合年增长率为 5.7%。

全球输血诊断市场正经历显着成长，这主要得益于安全输血技术日益增长的需求以及筛检技术的进步。外科手术、创伤病例和需要频繁输血的慢性疾病的增加，推动了对准确高效诊断解决方案的需求。卫生部门正积极致力于改善捐血筛检流程和病原体检测方法，进一步促进了市场扩张。技术创新正在革新输血诊断，自动化免疫血液学检查设备取代了手动仪器，最大限度地减少了人为误差，并提高了实验室效率。此外，核酸增幅检查(NAT) 的引入也大大提升了血液安全。分子检测方法、病原体减少系统、快速诊断试剂套件以及用于提高营运合规性和可追溯性的整合数位化管理解决方案的开发，也为市场带来了积极影响。

全球输血诊断市场驱动因素

全球输血诊断市场的主要驱动因素之一是血液传染疾病的日益增多以及对病人安全的日益重视。随着医疗机构和监管机构将安全输血实践放在首位，对先进诊断技术的需求不断增长，以确保血液製品的筛检和检测。对感染预防的日益重视，以及患者和临床医生对安全输血流程重要性的意识提升，正在推动输血诊断领域的创新和投资。因此，在技术进步和严格的安全通讯协定的支撑下，预计该市场将持续扩张。

限制全球输血诊断市场的因素

全球输血诊断市场的主要限制因素之一是先进诊断技术和设备的高成本。实施尖端检测方案通常需要大量资金投入，这对于预算有限的小型医院和诊断实验室来说难以负担。此外，复杂的监管要求和持续的操作人员培训需求进一步推高了成本。这些经济障碍可能会限制先进诊断方法的应用，最终阻碍市场成长潜力，并限制输血领域采用更新、更有效率的技术。

全球输血诊断市场趋势

全球输血诊断市场正呈现显着的自动化和数位连接趋势。实验室正越来越多地采用全自动平台，以简化检体处理、检测和结果解读的工作流程。这种转变不仅提高了检测的一致性，而且对于满足国家血库和大型医院等高通量环境的需求也至关重要。此外，实验室资讯管理系统 (LIMS) 和云端基础资料分析等数位化工具的集成，有助于提高医疗网路间的可追溯性、即时监控和无缝资料共用。这种数位化转型在加强监管合规性的同时，也提高了整个产业的营运效率。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2024）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术评估
• 监管环境
• 管道分析

血液输注诊断市场规模（按产品类型和复合年增长率划分）（2025-2032 年）

• 市场概览
• 装置
• 套件和试剂
• 软体和服务

血液输注诊断市场规模：检测类型及复合年增长率（2025-2032）

• 市场概览
• 传染病筛检（TTI）
• 血型鑑定/血型检测
• 相容性和交叉测试
• 核酸增幅检查（NAT）
• 其他输血诊断

依最终用户分類的输血诊断市场规模及复合年增长率（2025-2032 年）

• 市场概览
• 血库和输血服务
• 医院/临床实验室
• 诊断实验室
• 研究所

以技术及复合年增长率分類的输血诊断市场规模（2025-2032 年）

• 市场概览
• 血清学/免疫检测
• 分子诊断（PCR/NAT）
• 次世代定序/先进平台
• 自动化高通量系统

血液输注诊断市场规模及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2024 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2024 年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2022-2024年营收年比比较

主要企业简介

• Grifols, SA
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche Ltd f
• Quotient Limited
• Abbott Laboratories
• Ortho Clinical Diagnostics
• BioMerieux SA
• Siemens Healthineers
• Immucor, Inc.
• Danaher Corporation
• BD（Becton, Dickinson & Company）
• DiaSorin SpA
• Thermo Fisher Scientific Inc.
• BAG Healthcare GmbH
• Merck KGaA
• Sysmex Corporation
• Danaher
• Beckman Coulter Inc.
• Novartis AG
• Fresenius Kabi AG
• Cepheid

结论与建议

Global Blood Transfusion Diagnostics Market size was valued at USD 4.9 billion in 2023 and is poised to grow from USD 5.18 billion in 2024 to USD 8.07 billion by 2032, growing at a CAGR of 5.7% during the forecast period (2025-2032).

The global blood transfusion diagnostics market is witnessing considerable growth, driven by the increasing demand for safe transfusion practices and advancements in screening technologies. A rise in surgical procedures, trauma cases, and chronic diseases requiring frequent transfusions are fueling the need for accurate and efficient diagnostic solutions. Healthcare authorities are actively enhancing donor screening processes and pathogen detection methods, further propelling market expansion. Technological innovations have revolutionized blood transfusion diagnostics, with automated immunohematology analyzers replacing manual ones to minimize human error and boost lab efficiency. Moreover, the implementation of nucleic acid amplification testing (NAT) has significantly contributed to blood safety. The market is also benefiting from the development of molecular assays, pathogen-reduction systems, rapid diagnostic kits, and integrated digital management solutions for improved operational compliance and traceability.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Blood Transfusion Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Blood Transfusion Diagnostics Market Segments Analysis

Global Blood Transfusion Diagnostics Market is segmented by Product Type, Test Type, End-User, Technology and region. Based on Product Type, the market is segmented into Instruments, Kits & Reagents and Software & Services. Based on Test Type, the market is segmented into Infectious Disease Screening (TTIs), Blood Grouping & Typing, Compatibility & Cross-match Testing, Nucleic Acid Testing (NAT) and Other Transfusion Diagnostics. Based on End-User, the market is segmented into Blood Banks & Transfusion Services, Hospitals / Clinical Labs, Diagnostic Laboratories and Research Institutes. Based on Technology, the market is segmented into Serology / Immunoassay, Molecular Diagnostics (PCR/NAT), Next-Generation Sequencing / Advanced Platforms and Automation & High-Throughput Systems. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Blood Transfusion Diagnostics Market

One of the key market drivers for the global blood transfusion diagnostics market is the increasing prevalence of bloodborne diseases and the rising emphasis on patient safety. As healthcare providers and regulatory bodies prioritize safe transfusion practices, there is a growing demand for advanced diagnostic technologies that ensure the screening and testing of blood products. This heightened focus on preventing infections, coupled with rising awareness among patients and clinicians about the importance of safe transfusion processes, drives innovation and investment in blood transfusion diagnostics. As a result, the market is expected to expand, bolstered by technological advancements and stringent safety protocols.

Restraints in the Global Blood Transfusion Diagnostics Market

One significant market restraint for the global blood transfusion diagnostics market is the high cost associated with advanced diagnostic technologies and equipment. The implementation of state-of-the-art testing solutions often requires substantial capital investment, which may not be feasible for smaller hospitals and diagnostic laboratories that operate under budget constraints. Additionally, the complexity of regulatory requirements and the need for continuous operator training further escalate expenses. These financial barriers can limit accessibility to advanced diagnostic methods, ultimately hindering the market's growth potential and restricting the adoption of newer, more efficient technologies in the blood transfusion sector.

Market Trends of the Global Blood Transfusion Diagnostics Market

The Global Blood Transfusion Diagnostics market is experiencing a significant trend towards increased automation and digital connectivity. Laboratories are increasingly adopting fully automated platforms that streamline workflows for sample handling, testing, and result interpretation. This shift not only enhances consistency but is crucial for meeting the demands of high-volume environments like national blood banks and large hospitals. Additionally, the integration of digital tools such as Laboratory Information Management Systems (LIMS) and cloud-based data analytics is facilitating improved traceability, real-time monitoring, and seamless data sharing throughout the healthcare network. This digital transformation bolsters regulatory compliance and drives overall operational efficiency within the sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape
• Pipeline Analysis

Global Blood Transfusion Diagnostics Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Instruments
• Kits & Reagents
• Software & Services

Global Blood Transfusion Diagnostics Market Size by Test Type & CAGR (2025-2032)

• Market Overview
• Infectious Disease Screening (TTIs)
• Blood Grouping & Typing
• Compatibility & Cross-match Testing
• Nucleic Acid Testing (NAT)
• Other Transfusion Diagnostics

Global Blood Transfusion Diagnostics Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Blood Banks & Transfusion Services
• Hospitals / Clinical Labs
• Diagnostic Laboratories
• Research Institutes

Global Blood Transfusion Diagnostics Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Serology / Immunoassay
• Molecular Diagnostics (PCR/NAT)
• Next-Generation Sequencing / Advanced Platforms
• Automation & High-Throughput Systems

Global Blood Transfusion Diagnostics Market Size & CAGR (2025-2032)

• North America (Product Type, Test Type, End-User, Technology)
  • US
  • Canada
• Europe (Product Type, Test Type, End-User, Technology)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Test Type, End-User, Technology)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Test Type, End-User, Technology)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Test Type, End-User, Technology)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Grifols, S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd f
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quotient Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Immucor, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson & Company)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BAG Healthcare GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cepheid
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations